-
Something wrong with this record ?
Fluorinated 3,6,9-trisubstituted acridine derivatives as DNA interacting agents and topoisomerase inhibitors with A549 antiproliferative activity
P. Nunhart, E. Konkoľová, L. Janovec, R. Jendželovský, J. Vargová, J. Ševc, M. Matejová, B. Miltáková, P. Fedoročko, M. Kozurkova
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Acridines chemical synthesis chemistry pharmacology MeSH
- A549 Cells MeSH
- DNA Topoisomerases, Type I metabolism MeSH
- DNA Topoisomerases, Type II metabolism MeSH
- DNA drug effects MeSH
- Halogenation MeSH
- Topoisomerase I Inhibitors chemical synthesis chemistry pharmacology MeSH
- Topoisomerase II Inhibitors chemical synthesis chemistry pharmacology MeSH
- Humans MeSH
- Molecular Structure MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents chemical synthesis chemistry pharmacology MeSH
- Drug Screening Assays, Antitumor MeSH
- Cattle MeSH
- Dose-Response Relationship, Drug MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Cattle MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
A series of new 3,6,9-trisubstituted acridine derivatives with fluorine substituents on phenyl ring were synthesized and their interaction with calf thymus DNA was investigated. Analysis using UV-Vis absorbance spectra provided valuable information about the formation of the acridine-DNA complex. In addition, compounds 8b and 8d were found to display an increased binding affinity (K = 2.32 and 2.28 × 106 M-1, respectively). Topo I/II inhibition mode assays were also performed, and the results verify that the novel compounds display topoisomerase I and II inhibitory activity; compounds 8a, 8b and 8c completely inhibited topoisomerase I activity at a concentration of 60 × 10-6 M, but only compound 8d showed partial ability to inhibit topoisomerase II at concentrations of 30 and 50 × 10-6 M. The ability of the derivatives to impair cell proliferation was tested through an analysis of cell cycle distribution, quantification of cell number, viability studies, metabolic activity measurement and clonogenic assay. The content and localization of the derivatives in cells were analyzed using flow cytometry and fluorescence microscopy. The compounds 8b and 8d altered the physiochemical properties and improved antiproliferative activity in A549 human lung carcinoma cells (compound 8d displayed the highest level of activity, 4.25 × 10-6 M, after 48 h).
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012938
- 003
- CZ-PrNML
- 005
- 20210507101651.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bioorg.2019.103393 $2 doi
- 035 __
- $a (PubMed)31679839
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Nunhart, Patrik $u Department of Biochemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
- 245 10
- $a Fluorinated 3,6,9-trisubstituted acridine derivatives as DNA interacting agents and topoisomerase inhibitors with A549 antiproliferative activity / $c P. Nunhart, E. Konkoľová, L. Janovec, R. Jendželovský, J. Vargová, J. Ševc, M. Matejová, B. Miltáková, P. Fedoročko, M. Kozurkova
- 520 9_
- $a A series of new 3,6,9-trisubstituted acridine derivatives with fluorine substituents on phenyl ring were synthesized and their interaction with calf thymus DNA was investigated. Analysis using UV-Vis absorbance spectra provided valuable information about the formation of the acridine-DNA complex. In addition, compounds 8b and 8d were found to display an increased binding affinity (K = 2.32 and 2.28 × 106 M-1, respectively). Topo I/II inhibition mode assays were also performed, and the results verify that the novel compounds display topoisomerase I and II inhibitory activity; compounds 8a, 8b and 8c completely inhibited topoisomerase I activity at a concentration of 60 × 10-6 M, but only compound 8d showed partial ability to inhibit topoisomerase II at concentrations of 30 and 50 × 10-6 M. The ability of the derivatives to impair cell proliferation was tested through an analysis of cell cycle distribution, quantification of cell number, viability studies, metabolic activity measurement and clonogenic assay. The content and localization of the derivatives in cells were analyzed using flow cytometry and fluorescence microscopy. The compounds 8b and 8d altered the physiochemical properties and improved antiproliferative activity in A549 human lung carcinoma cells (compound 8d displayed the highest level of activity, 4.25 × 10-6 M, after 48 h).
- 650 _2
- $a buňky A549 $7 D000072283
- 650 _2
- $a akridiny $x chemická syntéza $x chemie $x farmakologie $7 D000166
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x chemická syntéza $x chemie $x farmakologie $7 D000970
- 650 _2
- $a skot $7 D002417
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a DNA $x účinky léků $7 D004247
- 650 _2
- $a DNA-topoisomerasy I $x metabolismus $7 D004264
- 650 _2
- $a DNA-topoisomerasy typu II $x metabolismus $7 D004250
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 _2
- $a halogenace $7 D054879
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a inhibitory topoisomerasy I $x chemická syntéza $x chemie $x farmakologie $7 D059004
- 650 _2
- $a inhibitory topoisomerasy II $x chemická syntéza $x chemie $x farmakologie $7 D059005
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Konkoľová, Eva $u Department of Biochemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
- 700 1_
- $a Janovec, Ladislav $u Department of Organic Chemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
- 700 1_
- $a Jendželovský, Rastislav $u Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
- 700 1_
- $a Vargová, Jana $u Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
- 700 1_
- $a Ševc, Juraj $u Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
- 700 1_
- $a Matejová, Mária $u Department of Organic Chemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
- 700 1_
- $a Miltáková, Beata $u Department of Organic Chemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
- 700 1_
- $a Fedoročko, Peter $u Department of Cellular Biology, Institute of Biology and Ecology, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic
- 700 1_
- $a Kozurkova, Mária $u Department of Biochemistry, Institute of Chemistry, Faculty of Science, P. J. Šafárik University in Košice, Šrobárova 2, 041 54 Košice, Slovak Republic; Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. Electronic address: maria.kozurkova@upjs.sk
- 773 0_
- $w MED00000771 $t Bioorganic chemistry $x 1090-2120 $g Roč. 94, č. - (2020), s. 103393
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31679839 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507101651 $b ABA008
- 999 __
- $a ok $b bmc $g 1651170 $s 1133317
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 94 $c - $d 103393 $e 20191023 $i 1090-2120 $m Bioorganic chemistry $n Bioorg Chem $x MED00000771
- LZP __
- $a Pubmed-20210420